Material Event (Form 8-K)

Item 8.01

Other Events

On May 18, 2026, Lifeward Ltd. (the "Company") announced the appointment of Keith D. Rose, M.D. as Chief Medical Officer of the Company, effective as of May 1, 2026.

Prior to this role, Dr. Rose served in positions of increasing responsibility at the Company since March 2023, including as National Medical Director, Medical Affairs - Neurosciences and Medical Director, Consultant, Medical Affairs - Neurosciences, and most recently as Vice President, Medical Affairs, Medical Director - Neurosciences. Before joining the Company, Dr. Rose served as the Medical Director, Medical Affairs at Biocodex, Inc. from November 2021 to June 2023 and Lead Clinical Research Scientist/Regional Manager in Oncology at Novocure, Inc. (NASDAQ: NVCR) from June 2020 to November 2021. Prior to those roles, Dr. Rose held various senior medical affairs and clinical leadership positions at Biocodex, Ipsen, Biosciences, Inc., Jazz Pharmaceuticals plc and Indivior PLC. Dr. Rose earned his Doctor of Medicine degree with distinction from The George Washington University School of Medicine and completed a five-year residency in Physical Medicine & Rehabilitation and Pediatric Medicine at Baylor College of Medicine.